CL
ACOR

CSS LLC’s Acorda Therapeutics ACOR Stock Holding History

CSS LLC’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-94
Closed -$8K – 1107
2020
Q4 		$8K Hold
94
– – ﹤0.01% 796
2020
Q3 		$6K Hold
94
– – ﹤0.01% 783
2020
Q2 		$8K Hold
94
– – ﹤0.01% 634
2020
Q1 		$11K Sell
94
-644
-87% -$127K ﹤0.01% 575
2019
Q4 		$181K Buy
+738
New +$186K 0.01% 513

Other funds holding ACOR

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
CCA
Canyon Capital Advisors Dallas, Texas $772M AUM 32.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CSS LLC's ACOR Position: Q1 2021 in Review

CSS LLC sold out of Acorda Therapeutics (ACOR) in Q1 2021, closing a stake of 94 shares — an estimated $8K sold.

CSS LLC first reported a position in ACOR in Q4 2019 and held it in 5 quarters. The position peaked at $181K in Q4 2019. 32 funds tracked by Wall St. Rank hold ACOR as of Q1 2021.

  • CSS LLC reported no remaining Acorda Therapeutics position as of Q1 2021 after selling out during the quarter.
  • CSS LLC sold 94 Acorda Therapeutics shares in Q1 2021, an estimated $8K.
  • CSS LLC first reported a position in Acorda Therapeutics in Q4 2019 and held it in 5 quarters.
  • CSS LLC's Acorda Therapeutics position peaked at $181K in Q4 2019.
  • 32 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2021.

Based on CSS LLC's 13F filing for Q1 2021, filed 17 May 2021.